58 related articles for article (PubMed ID: 29475197)
1. High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial.
Pasquali S; Colombo C; Pizzamiglio S; Verderio P; Callegaro D; Stacchiotti S; Martin Broto J; Lopez-Pousa A; Ferrari S; Poveda A; De Paoli A; Quagliuolo V; Jurado JC; Comandone A; Grignani G; De Sanctis R; Palassini E; Llomboart-Bosch A; Dei Tos AP; Casali PG; Picci P; Gronchi A
Eur J Cancer; 2018 Apr; 93():28-36. PubMed ID: 29475197
[TBL] [Abstract][Full Text] [Related]
2. Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: study protocol of the target selection phase III CHIC-STS trial.
Filleron T; Le Guellec S; Chevreau C; Cabarrou B; Lesluyes T; Lodin S; Massoubre A; Mounier M; Poublanc M; Chibon F; Valentin T
BMC Cancer; 2020 Jul; 20(1):716. PubMed ID: 32736540
[TBL] [Abstract][Full Text] [Related]
3. The Combined Use of Inflammation Markers, Modified Glasgow Prognostic Score, and Sarculator Nomogram in Extremity Soft Tissue Sarcoma: A Multicenter Observational Study.
Nakamura T; Takenaka S; Outani H; Hagi T; Tamiya H; Imura Y; Asanuma K; Sudo A
Cancers (Basel); 2024 Mar; 16(5):. PubMed ID: 38473433
[TBL] [Abstract][Full Text] [Related]
4. The inflammatory-nutritional score and nomogram for R0 resected head and neck soft tissue sarcoma.
Xu B; Qiu H; Ou B; Chen S; Du D; Liu Y; Zhang X; Liang Y
Oral Dis; 2024 Apr; 30(3):1139-1151. PubMed ID: 36630573
[TBL] [Abstract][Full Text] [Related]
5. Sarculator: how to improve further prognostication of all sarcomas.
Borghi A; Gronchi A
Curr Opin Oncol; 2024 Jul; 36(4):253-262. PubMed ID: 38726834
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications.
Pasquali S; Gronchi A
Ther Adv Med Oncol; 2017 Jun; 9(6):415-429. PubMed ID: 28607580
[TBL] [Abstract][Full Text] [Related]
7. Risk Stratification with Sarculator and MSKCC in Patients with Primary and Secondary Angiosarcoma.
Steubing Y; Ahmadi N; Puscz F; Wolff A; Hinzmann J; Reinkemeier F; Schmidt SV; Sogorski A; Von Glinski M; Becerikli M; Füth M; Zuchowski J; Brüggenhorst H; Huyghebaert T; Stricker I; Lehnhardt M; Wallner C
Life (Basel); 2024 Apr; 14(5):. PubMed ID: 38792591
[TBL] [Abstract][Full Text] [Related]
8. Incidence and survival of pediatric soft tissue sarcomas in moscow region, Russian Federation, 2000-2009.
Kachanov DY; Dobrenkov KV; Abdullaev RT; Shamanskaya TV; Varfolomeeva SR
Sarcoma; 2012; 2012():350806. PubMed ID: 22566750
[TBL] [Abstract][Full Text] [Related]
9. The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial.
Pasquali S; Pizzamiglio S; Touati N; Litiere S; Marreaud S; Kasper B; Gelderblom H; Stacchiotti S; Judson I; Dei Tos AP; Verderio P; Casali PG; Woll PJ; Gronchi A;
Eur J Cancer; 2019 Mar; 109():51-60. PubMed ID: 30690293
[TBL] [Abstract][Full Text] [Related]
10. Impact of perioperative chemotherapy and radiotherapy in patients with primary extremity soft tissue sarcoma: retrospective analysis across major histological subtypes and major reference centres.
Callegaro D; Miceli R; Bonvalot S; Ferguson P; Strauss DC; Levy A; Griffin A; Hayes AJ; Stacchiotti S; Le Pèchoux C; Smith MJ; Fiore M; Dei Tos AP; Smith HG; Catton C; Casali PG; Wunder JS; Gronchi A
Eur J Cancer; 2018 Dec; 105():19-27. PubMed ID: 30384013
[TBL] [Abstract][Full Text] [Related]
11. Targetable Alterations in Adult Patients With Soft-Tissue Sarcomas: Insights for Personalized Therapy.
Lucchesi C; Khalifa E; Laizet Y; Soubeyran I; Mathoulin-Pelissier S; Chomienne C; Italiano A
JAMA Oncol; 2018 Oct; 4(10):1398-1404. PubMed ID: 29801054
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups.
Gronchi A; Palmerini E; Quagliuolo V; Martin Broto J; Lopez Pousa A; Grignani G; Brunello A; Blay JY; Tendero O; Diaz Beveridge R; Ferraresi V; Lugowska I; Merlo DF; Fontana V; Marchesi E; Braglia L; Donati DM; Palassini E; Bianchi G; Marrari A; Morosi C; Stacchiotti S; Bagué S; Coindre JM; Dei Tos AP; Picci P; Bruzzi P; Casali PG
J Clin Oncol; 2020 Jul; 38(19):2178-2186. PubMed ID: 32421444
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy With Eribulin Following Potentially Curative Surgery in Patients With Localized Liposarcoma.
Steinbrecher O; Brodowicz T; Popov P; Lamm W
In Vivo; 2024; 38(1):385-389. PubMed ID: 38148100
[TBL] [Abstract][Full Text] [Related]
14. Quantitative proteomic studies addressing unmet clinical needs in sarcoma.
Connolly EA; Grimison PS; Horvath LG; Robinson PJ; Reddel RR
Front Oncol; 2023; 13():1126736. PubMed ID: 37197427
[TBL] [Abstract][Full Text] [Related]
15. Lifelong Imaging Surveillance is Indicated for Patients with Primary Retroperitoneal Liposarcoma.
Eckardt MA; Graham DS; Klingbeil KD; Lofftus SY; McCaw TR; Bailey MJ; Goldring CJ; Kendal JK; Kadera BE; Nelson SD; Dry SM; Kalbasi AK; Singh AS; Chmielowski B; Eilber FR; Eilber FC; Crompton JG
Ann Surg Oncol; 2023 May; 30(5):3097-3103. PubMed ID: 36581724
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling improves prognostication by nomogram in patients with soft-tissue sarcomas.
Crombé A; Spalato-Ceruso M; Michot A; Laizet Y; Lucchesi C; Toulmonde M; Bourcier K; Le Loarer F; Italiano A
Cancer Commun (Lond); 2022 Jun; 42(6):563-566. PubMed ID: 35132812
[No Abstract] [Full Text] [Related]
17. Comparison of Different Systemic Therapeutic Regimes in Resectable Soft-Tissue Sarcoma-Results of a Network Meta-Analysis.
Haussmann J; Matuschek C; Bölke E; Tamaskovics B; Corradini S; Wessalowski R; Maas K; Schmidt L; Orth K; Peiper M; Keitel V; Feldt T; Jensen BO; Luedde T; Fischer J; Knoefel WT; Ashmawy H; Pedotoa A; Kammers K; Budach W
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830786
[TBL] [Abstract][Full Text] [Related]
18. The Influence of Personalised Sarcoma Care (PERSARC) Prediction Modelling on Clinical Decision Making in a Multidisciplinary Setting.
Hagenmaier HSF; van Beeck AGK; Haas RL; van Praag VM; van Bodegom-Vos L; van der Hage JA; Krol S; Speetjens FM; Cleven AHG; Navas A; Kroon HM; Moeri-Schimmel RG; Leyerzapf NAC; van de Sande MAJ
Sarcoma; 2021; 2021():8851354. PubMed ID: 34720664
[TBL] [Abstract][Full Text] [Related]
19. Radiomics in the Setting of Neoadjuvant Radiotherapy: A New Approach for Tailored Treatment.
Nardone V; Boldrini L; Grassi R; Franceschini D; Morelli I; Becherini C; Loi M; Greto D; Desideri I
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298803
[TBL] [Abstract][Full Text] [Related]
20. Candidate Biomarkers for Specific Intraoperative Near-Infrared Imaging of Soft Tissue Sarcomas: A Systematic Review.
Rijs Z; Shifai AN; Bosma SE; Kuppen PJK; Vahrmeijer AL; Keereweer S; Bovée JVMG; van de Sande MAJ; Sier CFM; van Driel PBAA
Cancers (Basel); 2021 Feb; 13(3):. PubMed ID: 33535618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
